热门资讯> 正文

Editas Medicine股价因拟议股权发行而下跌

2026-05-26 18:53

Editas Medicine, Inc.(EDIT) 0
富国银行(WFC) 0

Editas Medicine (EDIT) shares fell nearly -12% premarket on Tuesday after the gene editing company launched an underwritten public offering of its common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and accompanying warrants.
Cantor and Wells Fargo Securities are acting as joint book-running managers for the proposed offering.

More on Editas Medicine

Editas Medicine, Inc. (EDIT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Editas Medicine GAAP EPS of -$0.06 beats by $0.20, revenue of $24.74M beats by $15.97M
Seeking Alpha’s Quant Rating on Editas Medicine
Historical earnings data for Editas Medicine
Financial information for Editas Medicine

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。